Abused NMDA Antagonists: Effects on Cortical Development
Abused NMDA Antagonists: Effects on Cortical Development
批准号:
6753569
负责人:
MARY A WILSON
金额:
$16.0万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-05-01 至 2006-04-30
关键词:
NMDA receptorsapoptosisautoradiographybrain derived neurotrophic factordevelopmental neurobiologydextromethorphandizocilpineexcitatory aminoacidfos proteinglutamate receptorimmunocytochemistryin situ hybridizationinjection /infusionketaminelaboratory ratmessenger RNAmorphologymorphometryneocortexneural plasticityneurotransmitter antagonistprotooncogenevibrissae
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This R21 application evaluates the hypothesis that the abused NMDA antagonists ketamine and dextromethorphan, by altering the function and expression of glutamate receptors, may have detrimental effects on the development of neocortex. Abuse of drugs that inhibit the NMDA receptor, such as PCP, ketamine and dextromethorphan, is increasing among adolescents. Because NMDA receptors play a critical role in the development of neo-cortical circuitry, abuse of NMDA antagonists has the potential to permanently alter the circuitry needed for normal sensory processing and cognition. NMDA antagonists may impair brain development in several ways: altering the developmentally programmed expression of neurotransmitter receptors, impairing the development of axonal and dendritic arbors, changing the precision of cortical maps, and increasing neuronal apoptosis. The proposed experiments use a well-characterized model of neocortical development that exhibits robust activity-dependent plasticity, the rodent whisker to barrel pathway. Three glutamate antagonists will be evaluated: 1) ketamine, a short-acting dissociative anesthetic that blocks the NMDAR channel, commonly used as an anesthetic in children and abused in the Club or rave scene; 2) dextromethorphan, a cough suppressant that blocks the NMDAR channel and is abused by adolescents; 3) MK-801, a longer- acting NMDAR channel blocker with documented effects on brain development. The specific aims use the rodent barrel field model to examine the effects of these NMDA antagonists on: 1) the development of somatosensory maps and the expression of glutamate receptors, 2) programmed cell death and BDNF expression in the postnatal rat brain, 3) experience-dependent cortical plasticity. The experiments will evaluate barrel field morphologic development and plasticity, expression of glutamate receptors, downstream effects on BDNF and c- fos mRNA expression and apoptosis. Based on our previous experience, the rodent barrel field model should provide a powerful, highly sensitive assessment of the potential impact of these abused drugs on neocortical development and plasticity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multi-modal treatment for neonatal HIE: hypothermia and dendrimer nanotherapy
-
批准号:8931789
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2014
-
负责人:MARY A WILSON
-
依托单位:
Effects of Lead on Cortical Development and Plasticity
-
批准号:7218650
-
项目类别:
-
资助金额:$33.29万
-
财政年份:2006
-
负责人:MARY A WILSON
-
依托单位:
Effects of Lead on Cortical Development and Plasticity
-
批准号:7771679
-
项目类别:
-
资助金额:$32.42万
-
财政年份:2006
-
负责人:MARY A WILSON
-
依托单位:
Effects of Lead on Cortical Development and Plasticity
-
批准号:7571641
-
项目类别:
-
资助金额:$32.75万
-
财政年份:2006
-
负责人:MARY A WILSON
-
依托单位:
Effects of Lead on Cortical Development and Plasticity
-
批准号:7105242
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2006
-
负责人:MARY A WILSON
-
依托单位:
Effects of Lead on Cortical Development and Plasticity
-
批准号:7367932
-
项目类别:
-
资助金额:$32.71万
-
财政年份:2006
-
负责人:MARY A WILSON
-
依托单位:
Abused NMDA Antagonists: Effects on Cortical Development
-
批准号:6625710
-
项目类别:
-
资助金额:$16.0万
-
财政年份:2002
-
负责人:MARY A WILSON
-
依托单位:
Abused NMDA Antagonists: Effects on Cortical Development
-
批准号:6478325
-
项目类别:
-
资助金额:$16.0万
-
财政年份:2002
-
负责人:MARY A WILSON
-
依托单位:
Multi-modal treatment for neonatal HIE: hypothermia and dendrimer nanotherapy
-
批准号:9318308
-
项目类别:
-
资助金额:$28.53万
-
财政年份:--
-
负责人:MARY A WILSON
-
依托单位:
Multi-modal treatment for neonatal HIE: hypothermia and dendrimer nanotherapy
-
批准号:9924012
-
项目类别:
-
资助金额:$17.53万
-
财政年份:--
-
负责人:MARY A WILSON
-
依托单位:
Multi-modal treatment for neonatal HIE: hypothermia and dendrimer nanotherapy
-
批准号:9111034
-
项目类别:
-
资助金额:$29.12万
-
财政年份:--
-
负责人:MARY A WILSON
-
依托单位:
RESEARCH COMPONENT
-
批准号:8846268
-
项目类别:
-
资助金额:$30.25万
-
财政年份:--
-
负责人:MARY A WILSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: